We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

10 hedge funds and large institutions have $209K invested in Zomedica Corp. in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% less capital invested

Capital invested by funds: $387K → $209K (-$177K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

57% less funds holding

Funds holding: 2310 (-13)

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

Holders
10
Holders Change
-13
Holders Change %
-56.52%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
14
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q2 2025 in Review

10 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q2 2025, worth a combined $209K — down 46% from $387K a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ZOM and 2 opened new positions — a net loss of 12 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Spire Wealth Management, adding an estimated $363. The largest seller was Brinker Capital Investments, exiting entirely with an estimated $20.7K sold.

  • 10 institutional investors held Zomedica Corp. (ZOM) as of Q2 2025, down from 23 in Q1 2025.
  • Funds reported $209K of Zomedica Corp. stock for Q2 2025, down 46% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q2 2025 and 14 closed out, a net change of -12 holders.
  • The largest Zomedica Corp. buyer in Q2 2025 was Spire Wealth Management, an estimated $363 added.
  • The largest Zomedica Corp. seller in Q2 2025 was Brinker Capital Investments, an estimated $20.7K sold.

Based on aggregated 13F filings for Q2 2025.